Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)
Conditions
Thymoma Malignant Recurrent
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Caen, Caen, France
Contact: Study coordinator (Simon DESHAYES, MD)Contact: Principal Investigator (Simon DESHAYES, MD)CLCC François BACLESSE, Caen, France
Contact: Study coordinator (Delphine LEROUGE, MD)Contact: Principal Investigator (Delphine LEROUGE, MD)CLCC Georges François Leclerc, Dijon, France
Contact: Study coordinator (Etienne MARTIN, MD)Contact: Principal Investigator (Etienne MARTIN, MD)Centre Oscar Lambret, Lille, France
Contact: Study coordinator (Florence LE TINIER, MD)Contact: Principal Investigator (Florence LE TINIER, MD)CHU Lyon, Lyon, France
Contact: Study coordinator (Thomas PIERRET, MD)Contact: Principal Investigator (Thomas PIERRET, MD)AP-HM Hôpital Nord, Marseille, France
Contact: Study coordinator (Pascal THOMAS, Pr)Contact: Principal Investigator (Pascal THOMAS, Pr)Institut du Cancer de Montpellier, Montpellier, France
Contact: Study coordinator (Xavier QUANTIN, Pr)Contact: Principal Investigator (Xavier QUANTIN, Pr)Antoine LACASSAGNE, Nice, France
Contact: Study coordinator (Jérôme DOYEN, MD)Contact: Principal Investigator (Jérôme DOYEN, MD)Institut Curie, Paris, France
Contact: Principal Investigator (Nicolas GIRARD, PR)Hôpital Européen Georges Pompidou, Paris, France
Contact: Study coordinator (Aurélia ALATI, MD)Contact: Principal Investigator (Aurélia ALATI, MD)Hôpital Bichat AP-HP, Paris, France
Contact: Study coordinator (Valérie GOUNANT, Pr)Contact: Principal Investigator (Valérie GOUNANT, Pr)CHU Haut Lévêque, Pessac, France
Contact: Study coordinator (POUYPOUDAT, MD)Contact: Principal Investigator (Claudia POUYPOUDAT, MD)CHU Rennes Hôpital Sud, Rennes, France
Contact: Study coordinator (Charles RICORDEL, MD)Contact: Principal Investigator (Charles RICORDEL, MD)CHU Rouen, Rouen, France
CLCC Henri Becquerel, Rouen, France
Contact: Study coordinator (Sébastien THUREAU, MD)Contact: Principal Investigator (Sébastien THUREAU, MD)Institut de Cancérologie de l'Ouest, Saint-Herblain, France
Contact: Study coordinator (François THILLAYS, MD)Contact: Principal Investigator (François THILLAYS, Pr)CHU Strasbourg, Strasbourg, France
Contact: Study coordinator (Pierre-Emmanuel FALCOZ, Pr)Contact: Principal Investigator (Pierre-Emmanuel FALCOZ, Pr)Institut Claudius Regaud, Toulouse, France
Contact: Study coordinator (Jonathan KHALIFA, MD)Contact: Principal Investigator (Jonathan KHALIFA, MD)CHRU Tours, Tours, France
Contact: Study coordinator (Eric PICHON, MD)Contact: Principal Investigator (Eric PICHON, MD)Institut de Cancérologie de Lorraine Nancy, Vandœuvre-lès-Nancy, France
Contact: Study coordinator (Mathilde CUENIN, MD)Contact: Principal Investigator (Mathilde CUENIN, MD)Gustave Roussy, Villejuif, France
Contact: Study coordinator (Angela BOTTICELLA, MD)Contact: Principal Investigator (Angela BOTTICELLA, MD)